Chesley Chen, Principal, CLA Life Sciences, is a mentor for two companies selected to participate in the 1st Cohort of the M2D2 IMPACT Accelerator Program. M2D2 (The Massachusetts Medical Device Development Center), a UMass Lowell and UMass Chan Medical School initiative, offers a wide range of services to the inventors and executives of Massachusetts smaller bio-tech and medical device companies. M2D2 has recently created IMPACT (Innovative Medical Products – Action, Commercialization, Technology), a 12-week accelerator program for inventors, entrepreneurs, start-ups and researchers. The program is designed for early to mid-stage biotech and medical device start-ups and will provide 1:1 mentorship, education workshops, access to lab equipment, and connections to resources needed for commercialization. Finalists for the IMPACT program were selected in October and will meet with mentors throughout the 12-week program to refine their business plans and presentations in preparation for Showcase Day on December 17th.
CLA exists to create opportunities for our clients, our people, and our communities through industry-focused wealth advisory, outsourcing, audit, tax, and consulting services. A proven business model is a critical component of any thriving life sciences company. Our professionals understand the operational and administrative challenges that demand your attention. With 7,400 people, more than 120 U.S. locations, and a global affiliation, we promise to know you and help you. Leveraging our own structure and experiences, we serve over 700 clients in the life sciences industry across the country, including businesses and the individuals within them so they can focus on keeping people alive and well.
For more information visit CLAconnect.com. Investment advisory services are offered through CliftonLarsonAllen Wealth Advisors, LLC, an SEC-registered investment advisor.